$UTHR

$591.35 -$1.49 (0.25%) Live

$UTHR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 42.9M shares outstanding

Who owns UTHR?

By type of holder

Institutions 97.0% Insiders 3.0% Everyone else 0.0%

Concentration Top 10 holders own 49.7%

BlackRock, Inc. 12.3% · Avoro Capital Advisors LLC 6.5%

Institutional ownership

97.0%

+0.3 pts vs last qtr

Institutional holders

877

+28 vs last qtr

Net shares bought

+121.8K

by institutions in Q2 2026

New / sold out

107 / 79

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +831.1K
Norges Bank NEW +694.8K

Biggest sellers in Q2 2026

Wellington Management Group LLP −885.2K
Janus Henderson Group PLC SOLD OUT −866.9K

Who is planning to sell?

Notices of proposed sale, last 12 months

$1.48B

100 notices from 15 people

Shares covered

2.8M

6.58% of the company

Arranged in advance

99%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Martine Rothblatt Director 10b5-1 $875M
James C Edgemond Officer 10b5-1 $185M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025

+2.4%

+0.26% a year

Each share's claim on the business

−2.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$2.75B vs $897M

over 10 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years74% 3–5 years6% 1–3 years8% Under 1 year12%

Quarterly turnover

12.2%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting UTHR on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	5.3M	12.34%	−105.1K (−1.9%)	≤2021	0.0%
Shares held by quarter Peak holding5.4M (Q1'25) Change over 8 quarters−22.9K Share of the company12.340% BlackRock, Inc.'s full portfolio →
AC Avoro Capital Advisors LLC	2.8M	6.48%	+147.8K (+5.6%)	≤2021	13.5%
Shares held by quarter Peak holding2.9M (Q3'24) Change over 8 quarters−81.1K Share of the company6.480% Avoro Capital Advisors LLC's full portfolio →

BlackRock, Inc.

5.3M

% of company

12.34%

Change vs last qtr

−105.1K (−1.9%)

Held since

≤2021

Avoro Capital Advisors LLC

2.8M

% of company

6.48%

Change vs last qtr

+147.8K (+5.6%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding United Therapeutics Corporation, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting UTHR on Form N-PORT; together they hold 35.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IC iShares Core S&P Mid-Cap ETF iShares Trust	$787M	1.5M	3.39%	0.63%	June 30, 2026
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$730M	1.3M	3.14%	0.03%	June 30, 2026

iShares Core S&P Mid-Cap ETF

iShares Trust

Position value

$787M

% of company

3.39%

% of the fund

0.63%

As of

June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$730M

% of company

3.14%

% of the fund

0.03%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding United Therapeutics Corporation and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
RM Rothblatt Martine A Insider	2.6M	6.01%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company6.010% Rothblatt Martine A's insider activity →
TT Thompson Tommy G Insider	50.5K	0.12%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.120% Thompson Tommy G's insider activity →

Rothblatt Martine A

Insider

2.6M

% of company

6.01%

Change vs last qtr

—

Held since

—

Thompson Tommy G

Insider

50.5K

% of company

0.12%

Change vs last qtr

—

Held since

—

12 more holders behind a free account

See every insider and 5%+ holder of United Therapeutics Corporation.

Comments